Major Beverage and Food Companies Evaluate Innovative Soy Protein Isolate for New Product Applications
CLARISOY is 100% soluble and completely transparent in acidic solutions, enabling applications in ready to drink beverages ranging down to pH 2.5 and lower. The solubility and transparency of CLARISOY allows for its use in a wide variety of beverages where traditional soy isolates are not appropriate.
06/03/09 Burcon NutraScience Corporation announces that it has entered into material transfer agreements (MTAs) and non-disclosure agreements (NDAs) with a number of globally recognized food, beverage and nutritional product companies for the evaluation of Burcon's innovative soy protein isolate, CLARISOY.
"We are delighted with the tremendous response from major beverage, food and nutritional product companies sampling and evaluating CLARISOY," stated Johann F. Tergesen, Burcon's President & COO, who added, "We look forward to working with these potential partners in creating opportunities and applications for CLARISOY."
CLARISOY is 100% soluble and completely transparent in acidic solutions, enabling applications in ready to drink beverages ranging down to pH 2.5 and lower. The solubility and transparency of CLARISOY allows for its use in a wide variety of beverages where traditional soy isolates are not appropriate. CLARISOY is heat stable, permitting hot-fill applications and eliminates the traditional 'beanie' taste of soy, giving beverages a cleaner flavor. As such, Burcon's CLARISOY shows great promise for use in a variety of beverage and food applications including nutritional, sports and energy drinks, juices and waters.
CLARISOY is expected to be price competitive with existing proteins and should be of particular interest to food and beverage manufacturers seeking an alternative to high dairy protein prices.
In a news release dated November 6, 2008, Burcon announced the appointment of BMO Capital Markets as its exclusive financial advisor to assist Burcon with a process to identify and pursue alternatives for the commercialization of its innovative protein extraction technologies, including its recently announced CLARISOY soy protein isolate technology. Today's announcement regarding the execution of MTA''s and NDA's and the associated sampling of Burcon''s CLARISOY by major end users is an integral part of that ongoing process.
